In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 443 for your search:
Drug:  ifosfamide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Unknown
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 21 at relapse
Sponsor: NCI
Protocol IDs: POG-9410, POG-SIMAL-8

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: NCI-85-C-62, NCI-T85-0096N, T85-0096

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 25
Sponsor: NCI
Protocol IDs: SJCRH-OS-86, NCI-T86-0086D, T86-0086

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 18
Sponsor: NCI
Protocol IDs: SJCRH-RMS-V, NCI-T86-0152D, T86-0152

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI
Protocol IDs: POG-8741/42, POG-8741, POG-8742

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: under 31
Sponsor: NCI
Protocol IDs: POG-8759

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-1588

9.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 18
Sponsor: NCI
Protocol IDs: CCG-3891

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Unknown
Age: 18 to 65
Sponsor: Other
Protocol IDs: LMU-DOLPHIN-1, EU-20220, NCT00045461

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: not over 30
Sponsor: NCI
Protocol IDs: CCG-7921, POG-9351, INT-0133

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: GOG-149, GOG-0149

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000063303, GOG-0150, ECOG-G150, NCT00002546

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor: Other
Protocol IDs: HOG-LUN93-2, NCI-V94-0422

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI, Other
Protocol IDs: CDR0000063574, MDA-DM-94017, NCI-T94-0040D, DM94-017, T94-0040, NCT00002565

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: FRE-FNCLCC-PALSAR-93, NCI-F94-0018

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: CDR0000063579, FRE-IT94, FRE-FNCLCC-IT94, NCI-F94-0019, NCT00002566

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 75 and under
Sponsor:
Protocol IDs: MRC-LU09, EU-94023

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor: Other
Protocol IDs: YALE-HIC-7653, NCI-V94-0553

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: at least 1 + under 20 at diag.
Sponsor: NCI
Protocol IDs: CCG-1941

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI
Protocol IDs: POG-9354, CCG-7942, INT-0154

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 to 69
Sponsor: Other
Protocol IDs: EORTC-62931, CAN-NCIC-SR3, SR3, NCT00002641

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MSKCC-95088, RP-56976-TAX-320, NCI-V96-0830

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: Other
Protocol IDs: EORTC-62933, E-EORTC-62933, SSG-EORTC-62933, SWOG-EORTC-62933, NCT00002764

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LU20, EU-95041
1     
New Search